Uncategorized

George King Bio-Medical, Inc. and NBDF History

Posted on

Last summer, we were visited by the National Bleeding Disorders Foundation. They are celebrating 75 years the same year we are celebrating our 50th! Since our beloved founder, George King, was a 2 term president, the NHF (now NBDF) wanted to make sure our company was included not only on their 75 year timeline, but   …Continue Reading


Unite For Bleeding Disorders Walk 2022

Posted on

Unite for Bleeding Disorders Walk through Midwest Hemophilia Association  George King Bio-Medical, Inc.  News Release OLATHE, Kan.- This past Saturday June 11, employees from George King Bio-Medical Inc. represented the company at the annual local chapter Midwest Hemophilia Association Unite for Bleeding Disorder Walk. The walk is held each year to support individuals with bleeding disorders.   …Continue Reading


Lab Week Coloring Pages

Posted on


Hypercoagulation and COVID

Posted on

In the evolving fight against COVID-19, scientists discovered patients have varying coagulation abnormalities. It is believed patients, “frequently have hypercoagulability caused by the immune response to the severe acute respiratory syndrome coronavirus-2 infection.” 1 These patients “may have a number of complex and varied coagulation abnormalities that create a hypercoagulable state.”2 The reasons behind the hypercoagulability   …Continue Reading


COVID and Coagulation

Posted on

The onset of COVID-19 presents many challenges to the medical community. Coagulation entered the fray with the discovery of abnormal clotting in patients with severe COVID-19. Doctors originally thought COVID-19 was a respiratory virus, “albeit a contagious and lethal one with no vaccine or treatment.” However, cases that did not fit the pattern of a respiratory virus   …Continue Reading


Q&A with Chris Bombardier

Posted on

Q: Our audience is primarily Laboratory Professionals, what message you would have for them? A: I actually started my career working in a hemophilia research lab where I enjoyed learning more of the scientific aspect of the disease. I still miss working in the lab, factor assays were my favorite part. They were like a puzzle and   …Continue Reading


Thoughts on Thawing

Posted on

The method of thawing a frozen sample in the coagulation lab has a significant effect on testing results. It is imperative that the samples be thawed properly. The preferred method is thawing for 3-5 minutes in a circulating water bath. The thawing time of 3-5 minutes is based on a 1.0 mL vial and may need   …Continue Reading


Lot to Lot Correlations

Posted on

Lot to lot correlations are common in today’s clinical laboratories. As explained in the recent CAP today article, “Differences between reagents and testing systems are known to contribute to test result variability, making crossover studies necessary when using new reagents or implementing new testing systems.”[1] Regulatory and accreditation standards require the lab to evaluate each   …Continue Reading


FVIII Activity: Chromogenic Assay Vs. Clot-Based?

Posted on

Factor VIII activity can be measured in different ways. Two of the assays used to assess the Factor VIII activity are the one-stage clotting assay and the chromogenic assay. The one-stage clotting assay is still the most widely used. The one stage clotting assay measures the extent a plasma sample corrects the coagulation time of   …Continue Reading


Factor Sensitivities – What’s the value, anyway? [Pun intended]

Posted on

Currently the global test used to detect intrinsic factor deficiencies in patients with bleeding is the activated partial thromboplastin time (APTT). The APTT reagent used should be sensitive to a reduction in coagulation factors such as FVIII and FIX that are commonly associated with bleeding. Literature states that it is desirable to have APTT systems   …Continue Reading